Every CVE Search/ Get API key

CVE-2023-53734

dawa-pharma-1.0 - SQL Injection via Email Parameter

8.7 High

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Attack profile

How easy it is to exploit

Attack vector
Network
Complexity
Low
Privileges needed
None
User interaction
None

What an attacker can affect

Confidentiality
High
Integrity
None
Availability
None

Exploit likelihood

0.57%Up 0.4 points since Dec 5, 2025
90%50%10%1%

What each source reports

CVE List Score used 8.7

dawa-pharma-1.0 - SQL Injection via Email Parameter

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Record
CVE-2023-53734
CVSS 4.0
8.7 HighCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
Weakness
CWE-89
Updated
2026-11-02
EUVDEUVD-2025-201278 8.7

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Record
EUVD-2025-201278
CVSS 4.0
8.7 HighCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
Updated
2026-11-02
GitHub AdvisoriesGHSA-6q4x-gx2j-mfgh 8.7

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing...

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Record
GHSA-6q4x-gx2j-mfgh
CVSS 4.0
8.7 HighCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Weakness
CWE-89
Updated
2026-11-02
NVD 8.7

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Record
CVE-2023-53734
CVSS 4.0
8.7 HighCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Weakness
CWE-89
Updated
2026-11-02

Affected products

History

History
RecordedChangedSources
first indexedCVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2023-53734 is a high vulnerability (CVSS 8.7) in Mayurik Dawa-pharma, published December 4, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.57%, the 47th percentile. No source names a fixed version.

References

Pages All vulnerabilities Browse Docs Sources Guide Get API key
MoveEnter Open